United States · 
What does Bristol Myers Squibb invest in?
Bristol Myers Squibb invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Pharma, Medicine and Drugs.
Bristol Myers Squibb highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series B and Series C: 67% of its rounds
- 03
Led 1 rounds
What they do
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- PharmaMedicineDrugs
- Based in
- Lawrence Township, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first15 appearances
- 2026
2 rounds
- Oct
- Jun
- 2025
1 round
- May
- 2024
1 round
- Mar
- 2023
1 round
- Oct
- 2019
2 rounds
- Nov
- May
- 2018
2 rounds
- Dec
- Oct
- 2017
4 rounds
- May
- Mar
- Jan
- Jan
- 2009
2 rounds
- Oct
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
5+funds on filenumbered funds in its name
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Medical information online
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it bought
Acquisitions by the firm itself
Cardioxyl Pharmaceuticals$2.0BNov 2015
Flexus Biosciences$1.3BFeb 2015
Galecto Biotech$444MNov 2014
f-star Biotech$475MOct 2014
iPierian$175MApr 2014
Inhibitex$2.5BJan 2012
Amira Pharmaceuticals$325MJul 2011
Adnexus$415MAug 2010
Medarex$2.4BJul 2009
Kosan Biosciences$190MMay 2008
Adnexus$415MSept 2007